JP2007504840A5 - - Google Patents

Download PDF

Info

Publication number
JP2007504840A5
JP2007504840A5 JP2006533063A JP2006533063A JP2007504840A5 JP 2007504840 A5 JP2007504840 A5 JP 2007504840A5 JP 2006533063 A JP2006533063 A JP 2006533063A JP 2006533063 A JP2006533063 A JP 2006533063A JP 2007504840 A5 JP2007504840 A5 JP 2007504840A5
Authority
JP
Japan
Prior art keywords
grp94
composition
nucleic acid
mouse
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006533063A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007504840A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/015120 external-priority patent/WO2004101766A2/en
Publication of JP2007504840A publication Critical patent/JP2007504840A/ja
Publication of JP2007504840A5 publication Critical patent/JP2007504840A5/ja
Pending legal-status Critical Current

Links

JP2006533063A 2003-05-12 2004-05-12 Grp94ベース組成物及びそれらの使用方法 Pending JP2007504840A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US46972303P 2003-05-12 2003-05-12
US47799003P 2003-06-12 2003-06-12
US47814903P 2003-06-12 2003-06-12
US56636204P 2004-04-28 2004-04-28
US56636304P 2004-04-28 2004-04-28
PCT/US2004/015120 WO2004101766A2 (en) 2003-05-12 2004-05-12 Grp94-based compositions and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2007504840A JP2007504840A (ja) 2007-03-08
JP2007504840A5 true JP2007504840A5 (https=) 2009-04-30

Family

ID=33459327

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006533063A Pending JP2007504840A (ja) 2003-05-12 2004-05-12 Grp94ベース組成物及びそれらの使用方法

Country Status (6)

Country Link
US (1) US7589174B2 (https=)
EP (1) EP1625141A4 (https=)
JP (1) JP2007504840A (https=)
AU (1) AU2004239338A1 (https=)
CA (1) CA2525385A1 (https=)
WO (1) WO2004101766A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080199486A1 (en) * 2003-05-12 2008-08-21 Yair Argon Grp94-based compositions and methods of use thereof
US20060029610A1 (en) * 2003-05-12 2006-02-09 Yair Argon GRP94-based compositions and methods of use thereof
EP2848942B1 (en) 2004-07-14 2017-03-08 The Regents of The University of California Biomarkers for early detection of ovarian cancer
US9488655B2 (en) * 2004-07-14 2016-11-08 The Regents Of The University Of California Biomarkers for detection of early- and late-stage endometrial cancer
US9487575B2 (en) 2004-07-14 2016-11-08 The Regents Of The University Of California Compositions and methods for treatment of gynecologic cancers
CN100419078C (zh) * 2005-11-18 2008-09-17 李川源 一种表达糖调节蛋白的方法及其应用
US8512708B2 (en) 2008-03-13 2013-08-20 Compugen Ltd. GP96 derived peptides
JP6078067B2 (ja) 2011-08-29 2017-02-08 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 炎症誘発性状態の治療および予防のためのhdl関連分子の使用
ES2769543T3 (es) * 2012-09-28 2020-06-26 Us Gov Sec Navy Calibración de nanoestructuras plasmónicas individuales para la biodetección cuantitativa
WO2020139834A1 (en) * 2018-12-24 2020-07-02 Visterra, Inc. Methods for identifying epitopes and paratopes
US20210277052A1 (en) * 2020-03-03 2021-09-09 Hauptman-Woodward Medical Research Institute Recombinant grp94 chaperones and methods of using the same to modulate glycosylation in fusion proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188964A (en) 1990-04-12 1993-02-23 Board Of Regents, The University Of Texas System Method and kit for the prognostication of breast cancer patient via heat shock/stress protein determination
US6017540A (en) * 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
US20020039583A1 (en) * 1999-09-30 2002-04-04 Subjeck John R. Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
WO2001072779A1 (en) 2000-03-24 2001-10-04 Duke University Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
US7235649B2 (en) 2000-03-24 2007-06-26 Duke University Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same
WO2002011669A2 (en) 2000-08-07 2002-02-14 Antigenics, Llc Compositions comprising heat shock proteins or alpha(2)macroglobulin, antigenic molecules and saponins, and methods of use thereof
AU2002217866A1 (en) 2000-11-06 2002-05-15 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Geldanamycin derivatives useful for the treatment of cancer
US20060029610A1 (en) 2003-05-12 2006-02-09 Yair Argon GRP94-based compositions and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2017500854A (ja) ポリペプチド、核酸およびその使用
US20030171326A1 (en) Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
JP2007504840A5 (https=)
CN110093369A (zh) 一种在H11位点条件性过表达Yap1基因小鼠模型的构建方法
US20150139999A1 (en) Interferon antagonists, antibodies thereto, and associated methods of use
CN110484615A (zh) lncRNA在病毒性心肌炎中调控巨噬细胞极化的应用
JP2023503033A (ja) マウス皮質の2/3層内のagmat陽性細胞中の遺伝子の特異的発現のためのプロモーター
US20130102656A1 (en) Use of a granulin or a granulin-like compound for the therapy or prophylaxis of chronic pain
JP2007504840A (ja) Grp94ベース組成物及びそれらの使用方法
CN110430899A (zh) 光感受灵敏度的抑制或减弱剂
JP4324473B2 (ja) 精子因子の配列
JP6871547B2 (ja) ピエリシン1aのadpリボシル化ドメイン遺伝子及びセリシン繭
US20090156467A1 (en) Thymic stromal lymphpoietin promoter and use therefor
Tang et al. p53 peptide prevents LITAF-induced TNF-alpha-mediated mouse lung lesions and endotoxic shock
CN115349015A (zh) 用于调节睡眠的药剂和方法
CN107537025B (zh) Metrnl蛋白或基因在调节抗菌肽表达中的应用
WO2021190226A1 (zh) 单碱基编辑介导的剪接修复在制备治疗脊髓性肌萎缩症中的应用
US20100111913A1 (en) Method of enhancing migration of neural precursor cells
CN113876937B (zh) Pzp的用途以及包括pzp的用于抵抗肥胖的药物组合物
KR20110117518A (ko) 다운 증후군 위험 영역 1이 과발현된 다운증후군 모델 세포주 제조방법
KR102243416B1 (ko) 한국형 중동호흡기증후군 코로나바이러스 감염에 감수성을 가지는 인간 dpp4 유전자를 폐 조직 특이적으로 발현하는 형질전환마우스와 이의 용도
AU754352B2 (en) Medicament
JP5240756B2 (ja) 軟骨疾患のモデル非ヒト動物
JP2009207465A (ja) Toll様受容体3遺伝子導入マウス
Liu et al. Influence of recombinant duck follistatin protein on embryonic muscle development and gene expressions